Randomized trial evaluates safety and effectiveness of responsive thalamic stimulation in drug-resistant epilepsy, indicating potential treatment options.
A randomized controlled trial (NCT05147571) assessed safety and effectiveness of bilateral centromedian nucleus (CM) responsive stimulation for treating drug-resistant idiopathic generalized epilepsy (IGE) with generalized tonic clonic (GTC) seizures
No takes yet. Share an insight, caveat, or question.
Morrell et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: